The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

Case report of tardive dyskinesia and parkinsonism associated with amoxapine therapy

Published Online:https://doi.org/10.1176/ajp.141.5.704

The authors describe a case of tardive dyskinesia and parkinsonism associated with amoxapine. Patients who develop acute parkinsonism while taking amoxapine may be at higher risk for tardive dyskinesia. The authors recommend that amoxapine be prescribed as carefully as other neuroleptics.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.